IRWD — Ironwood Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapTurnaround

Annual balance sheet for Ironwood Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	620	656	92.2	88.6	215
Net Total Accounts Receivable
Net Total Receivables	114	115	129	81.9	46.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	745	781	233	182	274
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	22.9	20.3	18.2	15.5	12.7
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,127	1,101	471	351	397
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	162	25.5	276	38.8	242
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	521	448	817	652	659
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	606	652	-346	-301	-262
Total Liabilities & Shareholders' Equity	1,127	1,101	471	351	397
Total Common Shares Outstanding